The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus
β Scribed by Hyejung Jung; Raja Bobba; Jiandong Su; Zhaleh Shariati-Sarabi; Dafna D. Gladman; Murray Urowitz; Wendy Lou; Paul R. Fortin
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 67 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Objective. To analyze changes in autoantibodies occurring in patients with systemic lupus erythematosus (SLE) treated with 4 infusions of the chimeric anti-tumor necrosis factor β£ (TNFβ£) antibody infliximab. Methods. In an open-label safety study, 7 patients with SLE were treated with infliximab at
## Objective: A pilot study was designed to assess the efficacy and safety of different exercise therapies on patient-reported fatigue and functional status. ## Methods: Ten patients with systemic lupus erythematosus (sle) were randomly placed in either an aerobic exercise group (group 1: n = 5)